ATA260486A - Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes

Info

Publication number: ATA260486A
Authority: AT; Austria
Prior art keywords: benzoxadiazol; dihydro; dimethyl; pharmaceutical compositions; active substance
Prior art date: 1985-10-01

Application number

AT0260486A

Other languages

English (en)

Other versions

AT402257B (de

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-01

Filing date

1986-09-30

Publication date

1996-08-15

1985-10-01 Priority claimed from GB858524135A external-priority patent/GB8524135D0/en

1985-10-07 Priority claimed from GB858524653A external-priority patent/GB8524653D0/en

1985-12-20 Priority claimed from GB858531419A external-priority patent/GB8531419D0/en

1986-02-07 Priority claimed from GB868603097A external-priority patent/GB8603097D0/en

1986-02-28 Priority claimed from GB868605037A external-priority patent/GB8605037D0/en

1986-09-30 Application filed by Sandoz Ag filed Critical Sandoz Ag

1996-08-15 Publication of ATA260486A publication Critical patent/ATA260486A/de

1997-03-25 Application granted granted Critical

1997-03-25 Publication of AT402257B publication Critical patent/AT402257B/de

Links

-1 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINE DICARBOXYLATE ESTER Chemical class 0.000 title 1
239000013543 active substance Substances 0.000 title 1
238000013270 controlled release Methods 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

AT0260486A 1985-10-01 1986-09-30 Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes AT402257B (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB858524135A GB8524135D0 (en)	1985-10-01	1985-10-01	Darodipine compositions
GB858524653A GB8524653D0 (en)	1985-10-07	1985-10-07	Pharmaceutical formulations
GB858531419A GB8531419D0 (en)	1985-12-20	1985-12-20	Pindolol compositions
GB868603097A GB8603097D0 (en)	1986-02-07	1986-02-07	Pharmaceutical formulations
GB868605037A GB8605037D0 (en)	1986-02-28	1986-02-28	Oral pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
ATA260486A true ATA260486A (de)	1996-08-15
AT402257B AT402257B (de)	1997-03-25

Family

ID=27516617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0260486A AT402257B (de)	1985-10-01	1986-09-30	Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes

Country Status (20)

Country	Link
KR (1)	KR920008817B1 (de)
AT (1)	AT402257B (de)
BE (1)	BE905516A (de)
CA (1)	CA1298784C (de)
CH (1)	CH669524A5 (de)
DE (1)	DE3632201C2 (de)
DK (1)	DK170016B1 (de)
ES (1)	ES2002508A6 (de)
FR (1)	FR2589732B1 (de)
GR (1)	GR862457B (de)
HK (1)	HK392A (de)
HU (1)	HU197201B (de)
IE (1)	IE59589B1 (de)
IL (1)	IL80182A (de)
LU (1)	LU86615A1 (de)
NL (1)	NL194822C (de)
NZ (1)	NZ217732A (de)
PT (1)	PT83456B (de)
SE (1)	SE503222C2 (de)
SG (1)	SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6440457B1 (en)	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
US6855729B2 (en) *	2001-02-20	2005-02-15	Timothy G. Dinan	Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
TW200616681A (en) *	2004-10-05	2006-06-01	Recordati Ireland Ltd	Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH630257A5 (en) *	1975-03-17	1982-06-15	Hoffmann La Roche	Sustained release formulation
CH639659A5 (de) *	1978-12-18	1983-11-30	Sandoz Ag	Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) *	1978-09-25	1980-11-19	Reinhard Huettenrauch	Verfahren zur herstellung fester a zneiformen
CA1146866A (en) *	1979-07-05	1983-05-24	Yamanouchi Pharmaceutical Co. Ltd.	Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) *	1980-05-21	1985-12-09	塩野義製薬株式会社	徐放性製剤
GB2084017B (en) *	1980-09-18	1984-08-22	Sandoz Ltd	Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) *	1981-12-18	1983-01-18	Forest Laboratories Inc.	Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) *	1982-10-07	1986-07-29	Kazuo Kigasawa	Soft buccal
GB2154874B (en) *	1984-02-29	1987-11-04	Sandoz Ltd	Bromoscriptine compositions
JPS61501511A (ja) *	1984-03-21	1986-07-24	アメリカン・ホ−ム・プロダクツ・コ−ポレイション	徐放性医薬カプセル
JPS6124516A (ja) *	1984-07-12	1986-02-03	Fujisawa Pharmaceut Co Ltd	持続性錠剤

1986
- 1986-09-19 NL NL8602370A patent/NL194822C/nl not_active IP Right Cessation
- 1986-09-19 HU HU864004A patent/HU197201B/hu unknown
- 1986-09-22 CH CH3780/86A patent/CH669524A5/de not_active IP Right Cessation
- 1986-09-23 DE DE3632201A patent/DE3632201C2/de not_active Expired - Lifetime
- 1986-09-29 IE IE256586A patent/IE59589B1/en not_active IP Right Cessation
- 1986-09-29 GR GR862457A patent/GR862457B/el unknown
- 1986-09-29 DK DK464686A patent/DK170016B1/da not_active IP Right Cessation
- 1986-09-29 KR KR1019860008136A patent/KR920008817B1/ko not_active Expired
- 1986-09-29 NZ NZ217732A patent/NZ217732A/xx unknown
- 1986-09-29 IL IL80182A patent/IL80182A/xx not_active IP Right Cessation
- 1986-09-29 CA CA000519302A patent/CA1298784C/en not_active Expired - Lifetime
- 1986-09-29 SE SE8604112A patent/SE503222C2/sv not_active IP Right Cessation
- 1986-09-29 PT PT83456A patent/PT83456B/pt unknown
- 1986-09-30 BE BE1/011554A patent/BE905516A/fr not_active IP Right Cessation
- 1986-09-30 AT AT0260486A patent/AT402257B/de not_active IP Right Cessation
- 1986-09-30 ES ES8602313A patent/ES2002508A6/es not_active Expired
- 1986-09-30 LU LU86615A patent/LU86615A1/fr unknown
- 1986-10-01 FR FR868613668A patent/FR2589732B1/fr not_active Expired
1991
- 1991-12-04 SG SG1033/91A patent/SG103391G/en unknown
1992
- 1992-01-02 HK HK3/92A patent/HK392A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE8604112D0 (sv)	1986-09-29
AT402257B (de)	1997-03-25
HK392A (en)	1992-01-10
NL194822B (nl)	2002-12-02
SG103391G (en)	1992-01-17
IE59589B1 (en)	1994-03-09
PT83456B (pt)	1989-05-12
IE862565L (en)	1987-04-01
NZ217732A (en)	1990-07-26
CA1298784C (en)	1992-04-14
NL8602370A (nl)	1987-05-04
HUT44701A (en)	1988-04-28
NL194822C (nl)	2003-04-03
DK170016B1 (da)	1995-05-01
IL80182A (en)	1991-01-31
DE3632201A1 (de)	1987-04-02
IL80182A0 (en)	1986-12-31
HU197201B (en)	1989-03-28
KR920008817B1 (ko)	1992-10-09
FR2589732B1 (fr)	1989-07-13
SE8604112L (sv)	1987-04-02
PT83456A (en)	1986-10-01
BE905516A (fr)	1987-03-30
SE503222C2 (sv)	1996-04-22
CH669524A5 (de)	1989-03-31
DE3632201C2 (de)	1997-05-07
FR2589732A1 (fr)	1987-05-15
KR870003777A (ko)	1987-05-04
DK464686D0 (da)	1986-09-29
GR862457B (en)	1987-01-29
DK464686A (da)	1987-04-02
ES2002508A6 (es)	1988-08-16
LU86615A1 (fr)	1987-04-02

Similar Documents

Publication	Publication Date	Title
JPS55301A (en)	1980-01-05	1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
ATA245485A (de)	1991-07-15	Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
PT84496A (de)	1987-04-01	Kristalline wasserfreie 6-form von 2-]4-(2-furoyl)-(2-piperazin)-1-yl"-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung
FI881978L (fi)	1988-11-16	Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
PH27356A (en)	1993-06-22	Annelated tetrahydropyridine acetic acid derivatives pharmaceutical composition containing said compound and method of use thereof
ATA156187A (de)	1995-06-15	Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
ATA260486A (de)	1996-08-15	Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes
ATA82386A (de)	1990-09-15	Verfahren zur herstellung von neuen 7beta-(2-(2amino-4-thiazolyl)-alkenoylamino)-3-cephem-4- carbonsaeureestern
DE3673708D1 (de)	1990-10-04	1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ATA327685A (de)	1992-01-15	Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
ES8801543A1 (es)	1988-02-16	Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
DE3677838D1 (de)	1991-04-11	Verfahren zur herstellung von alkylestern von 3,4-epoxybuttersaeure.
DE68908121D1 (de)	1993-09-09	Verfahren zur herstellung von 5-cyanovaleriansaeure und ihrer ester unter verwendung von zyklischen co-loesungsmitteln.
ATA874476A (de)	1979-03-15	Verfahren zur herstellung von neuen tetrahydro- pyridin und piperidinderivaten und ihren saeureadditionssalzen
DE68923159D1 (de)	1995-07-27	Verfahren zur Herstellung von 1,4-Dihydropyridin-Derivaten.
DE69114743D1 (de)	1996-01-04	Verfahren zur Herstellung von Fluormethyl-substituierten Dihydropyridin-carbodithioaten.
AT385990B (de)	1988-06-10	Verfahren zur herstellung von neuen racemischen und optisch aktiven eburnan-oxim-derivaten sowie von saeureadditions-salzen derselben
DE3861897D1 (de)	1991-04-11	Verfahren zur herstellung von 4-hydroxy-2,2,6,6-tetramethyl-piperidin.
ATA326986A (de)	1991-09-15	Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
DK169185D0 (da)	1985-04-15	Dihydropyridin-3,5-dicarboxylsyreesterderivater, fremgangsmaade tilfremstilling heraf og farmaceutiske praeparater indeholdende disse
DK468385A (da)	1986-07-25	Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
ATE118205T1 (de)	1995-02-15	Verfahren zur herstellung der optischen isomeren von 1,4-dihydro-5-isopropoxy-2-methyl-4-(2- trifluormethylphenyl)-1,6-naphthyridin-3- carbonsäure-ethyl-ester und 1,4-dihydro-5-
DE69021518D1 (de)	1995-09-14	1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridin-3-carbonsäure-1-azabicyclo[2.2.2]oct-3-ylester-Isomere.
ATA223986A (de)	1991-07-15	Verfahren zur herstellung von neuen dihydropyridinderivaten
DE68922605D1 (de)	1995-06-14	Verfahren zur Herstellung von (-)2-(2-(2-Aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin, und Zwischenprodukt zu dessen Herstellung.

Legal Events

Date	Code	Title	Description
2007-06-15	ELA	Expired due to lapse of time